Regulatory Uncertainty And Elevated CapEx Will Curb Returns

Shared on09 Apr 25
Fair value Increased 4.78%

Shared on02 Apr 25
Fair value Increased 3.44%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.065%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Decreased 7.30%

AnalystConsensusTarget has increased revenue growth from 3.4% to 4.5%.